Redmile Group, LLC Soma Logic, Inc. Transaction History

Redmile Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.76 - $2.83 $2.64 Million - $4.25 Million	-1,500,000 Reduced 80.18%	370,839 $938,000
Q1 2023 May 15, 2023	BUY	$2.13 - $3.6 $789,887 - $1.34 Million	370,839 Added 24.72%	1,870,839 $4.77 Million
Q4 2022 Feb 14, 2023	SELL	$2.05 - $3.47 $760,219 - $1.29 Million	-370,839 Reduced 19.82%	1,500,000 $3.76 Million
Q3 2022 Nov 14, 2022	SELL	$0.63 - $5.47 $137,214 - $1.19 Million	-217,800 Reduced 10.43%	1,870,839 $5.43 Million
Q2 2022 Aug 15, 2022	SELL	$4.27 - $8.26 $7.76 Million - $15 Million	-1,818,131 Reduced 46.54%	2,088,639 $9.44 Million
Q1 2022 May 16, 2022	SELL	$7.07 - $11.62 $1.67 Million - $2.74 Million	-236,000 Reduced 5.7%	3,906,770 $31.3 Million
Q4 2021 Feb 14, 2022	BUY	$10.49 - $14.28 $1.79 Million - $2.43 Million	170,500 Added 4.29%	4,142,770 $48.2 Million
Q3 2021 Nov 15, 2021	BUY	$9.94 - $12.77 $39.5 Million - $50.7 Million	3,972,270 New	3,972,270 $49.2 Million

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.